Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community
Asthma and rhinitis are common comorbidities that amplify the burden of each disease. They are both characterized by poor symptom control, low adherence to clinical management guidelines, and high levels of patient self-management. Therefore, this study aims to investigate the prevalence of self-rep...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/11/4/115 |
| _version_ | 1827728830793515008 |
|---|---|
| author | Sara Alamyar Elizabeth Azzi Pamela Srour-Alphonse Rachel House Biljana Cvetkovski Vicky Kritikos Sinthia Bosnic-Anticevich |
| author_facet | Sara Alamyar Elizabeth Azzi Pamela Srour-Alphonse Rachel House Biljana Cvetkovski Vicky Kritikos Sinthia Bosnic-Anticevich |
| author_sort | Sara Alamyar |
| collection | DOAJ |
| description | Asthma and rhinitis are common comorbidities that amplify the burden of each disease. They are both characterized by poor symptom control, low adherence to clinical management guidelines, and high levels of patient self-management. Therefore, this study aims to investigate the prevalence of self-reported rhinitis symptoms in people with asthma purchasing Short-Acting Beta Agonist (SABA) reliever medication from a community pharmacy and compare the medication-related behavioral characteristics among those who self-report rhinitis symptoms and those who do not. Data were analyzed from 333 people with asthma who visited one of eighteen community pharmacies in New South Wales from 2017–2018 to purchase SABA and completed a self-administered questionnaire. Participants who reported rhinitis symptoms (71%), compared to those who did not, were significantly more likely to have coexisting gastroesophageal reflux disease (GERD), overuse SABA, and experience side effects. They may have been prescribed daily preventer medication but forget to take it, and worry about its side effects. They were also more likely to experience moderate-to-severe rhinitis (74.0%), inaccurately perceive their asthma as well-controlled (50.0% self-determined vs. 14.8% clinical-guideline defined), and unlikely to use rhinitis medications (26.2%) or daily preventer medication (26.7%). These findings enhance our understanding of this cohort and allow us to identify interventions to improve patient outcomes. |
| first_indexed | 2024-03-10T23:38:28Z |
| format | Article |
| id | doaj.art-4033934233a84c8d8ca2da990fcb625e |
| institution | Directory Open Access Journal |
| issn | 2226-4787 |
| language | English |
| last_indexed | 2024-03-10T23:38:28Z |
| publishDate | 2023-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacy |
| spelling | doaj.art-4033934233a84c8d8ca2da990fcb625e2023-11-19T02:38:08ZengMDPI AGPharmacy2226-47872023-07-0111411510.3390/pharmacy11040115Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the CommunitySara Alamyar0Elizabeth Azzi1Pamela Srour-Alphonse2Rachel House3Biljana Cvetkovski4Vicky Kritikos5Sinthia Bosnic-Anticevich6Sydney Medical School, The University of Sydney, Sydney, NSW 2006, AustraliaQuality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, AustraliaQuality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, AustraliaQuality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, AustraliaQuality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, AustraliaQuality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, AustraliaQuality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, AustraliaAsthma and rhinitis are common comorbidities that amplify the burden of each disease. They are both characterized by poor symptom control, low adherence to clinical management guidelines, and high levels of patient self-management. Therefore, this study aims to investigate the prevalence of self-reported rhinitis symptoms in people with asthma purchasing Short-Acting Beta Agonist (SABA) reliever medication from a community pharmacy and compare the medication-related behavioral characteristics among those who self-report rhinitis symptoms and those who do not. Data were analyzed from 333 people with asthma who visited one of eighteen community pharmacies in New South Wales from 2017–2018 to purchase SABA and completed a self-administered questionnaire. Participants who reported rhinitis symptoms (71%), compared to those who did not, were significantly more likely to have coexisting gastroesophageal reflux disease (GERD), overuse SABA, and experience side effects. They may have been prescribed daily preventer medication but forget to take it, and worry about its side effects. They were also more likely to experience moderate-to-severe rhinitis (74.0%), inaccurately perceive their asthma as well-controlled (50.0% self-determined vs. 14.8% clinical-guideline defined), and unlikely to use rhinitis medications (26.2%) or daily preventer medication (26.7%). These findings enhance our understanding of this cohort and allow us to identify interventions to improve patient outcomes.https://www.mdpi.com/2226-4787/11/4/115allergic rhinitisasthmaattitudesbehaviorsmedicationperception |
| spellingShingle | Sara Alamyar Elizabeth Azzi Pamela Srour-Alphonse Rachel House Biljana Cvetkovski Vicky Kritikos Sinthia Bosnic-Anticevich Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community Pharmacy allergic rhinitis asthma attitudes behaviors medication perception |
| title | Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community |
| title_full | Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community |
| title_fullStr | Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community |
| title_full_unstemmed | Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community |
| title_short | Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community |
| title_sort | uncovering the burden of rhinitis in patients purchasing nonprescription short acting β agonist saba in the community |
| topic | allergic rhinitis asthma attitudes behaviors medication perception |
| url | https://www.mdpi.com/2226-4787/11/4/115 |
| work_keys_str_mv | AT saraalamyar uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity AT elizabethazzi uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity AT pamelasrouralphonse uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity AT rachelhouse uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity AT biljanacvetkovski uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity AT vickykritikos uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity AT sinthiabosnicanticevich uncoveringtheburdenofrhinitisinpatientspurchasingnonprescriptionshortactingbagonistsabainthecommunity |